The 21 Days to Health & Beyond detox diet is simple and austere and easy to do if you have the desire to do it.
It is not, repeat NOT, a program for people with no will power.
In a nutshell, with this do-it-yourself detox/cleansing program, for three weeks you'll eat no dairy foods, no meat or animal foods other than a tablespoon a day of cod liver oil, no white flour, no sugar, and no salt.
Instead of the usual American diet of junk and highly processed foods, you'll live on delicious recipes composed of fruit, vegetables, nuts, seeds, and whole grains.
After you complete the 21-day program, you'll transition to the Health & Beyond Living to the Max program, which features a healthy traditional diet of whole foods from both plant and animal kingdoms that will help you feel great for the rest of your life.
More Information
All e-book about body, headache, vitamins, cancer, asthma, disease, tuberculosis and anything that related with health or medical
Tuesday, November 20, 2007
Thursday, November 15, 2007
43 Nutrition Secrets Revealed

Have you got a meal plan and diet strategy ?
If you don't then, it's a bit like driving in the countryside without a road map - you never know where you'll end up.
It's nothing new, you probably already know you need a strategy. The difficulty is HOW do you get a diet strategy that will work for you ?
Read Online (PDF)
10 Herbal Tea Recipes
Discover the 10 natural herbal tea recipes used to treat illness and disease for hundreds of years. More Information
Effects Of Calcium Aspartate Anhydrous On Osteoporosis Treatment
Background Osteoporosis is a common metabolic bone disease. We conducted a multi-center, double- placebo, double-blind study to verify the effects of calcium aspartate anhydrous on osteoporosis. Methods 1,306 patients with an initial t-score of –1.5 or lower were randomly assigned to receive calcium aspartate anhydrous (CalAA, 520mg elemental per day) and a placebo, or calcium citrate (1500 mg elemental per day) and vitamin D (1000 IU per day), or two placebos. Results At 3 months, the bone mineral density (BMD) at the lumbar spine had increased by a mean of 4.07% in the CalAA group, 0.64 percent in the calcium citrate group and there was no significant change in the double-placebo group. The BMD of the total hip had increased by a mean of 3.37 percent in the CalAA group. No significant change was detected in the calcium citrate group or the double-placebo group. At 12 months, lumbar spine BMD had increased by a mean of 5.66 percent in the CalAA group, while the calcium citrate group and the double-placebo group saw decline of 0.51% and 0.75% respectively. Total hip BMD had increased by a mean of 4.11 percent in the CalAA group while there was no significant change in the calcium citrate group. Total hip BMD declined by a mean of 1.17% in the double-placebo group.
Read Online (PDF)
Read Online (PDF)
Medications For Prevention And Treatment Of Osteoporosis
Medications for Prevention and Treatment of Osteoporosis. steoporosis is a disease where the strength of bones is less than normal, making them more susceptible to fracture, or breaking, than normal bones. Any bone will break if subjected to enough force, but a bone with osteoporosis may break with very little trauma, or sometimes with no trauma at all. Fractures can cause pain, loss of independence, and shorten your life. The best time to detect osteoporosis is before a fracture happens, and the best way to do that is with a bone density test. The “gold-standard” method of measuring bone density is by DXA (Dual-energy X-ray Absorptiometry) of the spine and hip. If the “T-score” on the DXA test is less than or equal to –2.5, then a diagnosis of osteoporosis may be made. If you have osteoporosis, or low bone density, there are medications that can strengthen your bones and reduce the future risk of fractures. Medications can help whether or not you have already had a fracture, whether you are male or female, and even if you are very old. Since there are many medications for osteoporosis, it is important that you have a good understanding of the risks and benefits with each of them. The more you know, the better you are able to select the one that is best for you.
Read Online
Read Online
Handbook Of Clinical Neurology
File Summary
Molecular Toxicology of Marine Toxins A. Specific Receptor Site Interaction: Physiologic Biomarkers of Susceptibility The naturally-occurring marine toxins responsible for Paralytic Shellfish Poisoning, Neurotoxic Shellfish Poisoning, Amnesic Shellfish Poisoning, Diarrheic Shellfish Poisoning, Fugu Poisoning, and Ciguatera exert their effects in the nanomole to picomole per kg body weight ranges (Yasumoto and Murata 1993). By virtue of their highly specific and potent deleterious effects on living systems, specific receptor-ligands were postulated as the pharmacologically significant event in the onset of toxicity even before the chemical identity of the toxin(s) were known (see Baden, 1983 for a review). Of those toxins now known to the seafood safety regulators, four types are known to interact with specific orphan receptors located on nerve membrane glycoproteins, one type is a potent muscle enzyme inhibitor, and one interacts specifically with a central nervous system neurotransmitter receptor site
Read Online (PDF)
Molecular Toxicology of Marine Toxins A. Specific Receptor Site Interaction: Physiologic Biomarkers of Susceptibility The naturally-occurring marine toxins responsible for Paralytic Shellfish Poisoning, Neurotoxic Shellfish Poisoning, Amnesic Shellfish Poisoning, Diarrheic Shellfish Poisoning, Fugu Poisoning, and Ciguatera exert their effects in the nanomole to picomole per kg body weight ranges (Yasumoto and Murata 1993). By virtue of their highly specific and potent deleterious effects on living systems, specific receptor-ligands were postulated as the pharmacologically significant event in the onset of toxicity even before the chemical identity of the toxin(s) were known (see Baden, 1983 for a review). Of those toxins now known to the seafood safety regulators, four types are known to interact with specific orphan receptors located on nerve membrane glycoproteins, one type is a potent muscle enzyme inhibitor, and one interacts specifically with a central nervous system neurotransmitter receptor site
Read Online (PDF)
Tuesday, November 13, 2007
Back and Neck Pain
The first step in relieving your back and neck pain is to understand the mechanics of your spine (or backbone). If you can determine where the pain is coming from, you are on your way to taking control and finding relief.
Your spine extends from the base of your skull to the top of your sacrum (or tailbone) that connects to the top of your pelvis (to which your hips join). The 44 bones of your spine are called vertebrae (7 in neck or cervical, 12 in chest or thoracic, and 5 in lower back or lumbar). Between each hard vertebra are soft discs which are jelly-filled shock-absorbers that allow the spine to stay flexible and mobile, while also supporting your body weight and the weight of anything you lift.
Dr Fong Shee Yan, MBBS FRCSEd(Orth) MMed(Surg) FAMS(Orth)
Read Online (PDF)
Read Online (DOC)
Your spine extends from the base of your skull to the top of your sacrum (or tailbone) that connects to the top of your pelvis (to which your hips join). The 44 bones of your spine are called vertebrae (7 in neck or cervical, 12 in chest or thoracic, and 5 in lower back or lumbar). Between each hard vertebra are soft discs which are jelly-filled shock-absorbers that allow the spine to stay flexible and mobile, while also supporting your body weight and the weight of anything you lift.
Dr Fong Shee Yan, MBBS FRCSEd(Orth) MMed(Surg) FAMS(Orth)
Read Online (PDF)
Read Online (DOC)
Blue book - Guidelines for the control of infectious diseases

The blue book: guidelines for the control of infectious diseases has been published by the Communicable Diseases Section, Public Health Group, Victorian Department of Human Services, to assist public health practitioners in the prevention and control of infectious diseases.
The Department of Human Services is committed to enhancing and protecting the health and well-being of all Victorians. Our challenge, together with public health practitioners, is to reduce community risk from communicable disease in Victoria through the implementation of patient focused and population focused control strategies based on surveillance and risk assessment.
More Information
Read Online (PDF)
Friday, November 9, 2007
Bone Health And Osteoporosis: A Report Of The Surgeon General
By United States Public Health Service Surgeon General of the United States
This first-ever Surgeon General’s Report on bone health and osteoporosis illustrates the large burden that bone disease places on our Nation and its citizens. Like other chronic diseases that disproportionately affect the elderly, the prevalence of bone disease and fractures is projected to increase markedly as the population ages. If these predictions come true, bone disease and fractures will have a tremendous negative impact on the future well-being of Americans. But as this report makes clear, they need not come true: by working together we can change the picture of aging in America. Osteoporosis, fractures, and other chronic diseases no longer should be thought of as an inevitable part of growing old. By focusing on prevention and lifestyle changes, including physical activity and nutrition, as well as early diagnosis and appropriate treatment, Americans can avoid much of the damaging impact of bone disease and other chronic diseases.
This Surgeon General’s Report brings together for the first time the scientific evidence related to the prevention, assessment, diagnosis, and treatment of bone disease. More importantly, it provides a framework for moving forward. The report will be another effective tool in educating Americans about how they can promote bone health throughout their lives.
This first-ever Surgeon General’s Report on bone health and osteoporosis provides much needed information on bone health, an often overlooked aspect of physical health. This report follows in the tradition of previous Surgeon Generals’ reports by identifying the relevant scientific data, rigorously evaluating and summarizing the evidence, and determining conclusions.
Read Online (PDF)
This first-ever Surgeon General’s Report on bone health and osteoporosis illustrates the large burden that bone disease places on our Nation and its citizens. Like other chronic diseases that disproportionately affect the elderly, the prevalence of bone disease and fractures is projected to increase markedly as the population ages. If these predictions come true, bone disease and fractures will have a tremendous negative impact on the future well-being of Americans. But as this report makes clear, they need not come true: by working together we can change the picture of aging in America. Osteoporosis, fractures, and other chronic diseases no longer should be thought of as an inevitable part of growing old. By focusing on prevention and lifestyle changes, including physical activity and nutrition, as well as early diagnosis and appropriate treatment, Americans can avoid much of the damaging impact of bone disease and other chronic diseases.
This Surgeon General’s Report brings together for the first time the scientific evidence related to the prevention, assessment, diagnosis, and treatment of bone disease. More importantly, it provides a framework for moving forward. The report will be another effective tool in educating Americans about how they can promote bone health throughout their lives.
This first-ever Surgeon General’s Report on bone health and osteoporosis provides much needed information on bone health, an often overlooked aspect of physical health. This report follows in the tradition of previous Surgeon Generals’ reports by identifying the relevant scientific data, rigorously evaluating and summarizing the evidence, and determining conclusions.
Read Online (PDF)
Subscribe to:
Posts (Atom)
